期刊文献+

6-氨甲基喹啉的合成 被引量:1

Synthesis of 6-aminomethylquinoline
下载PDF
导出
摘要 目的改进6-氨甲基喹啉的合成工艺。方法以6-甲基喹啉、溴代琥珀酰亚胺、邻苯二甲酰亚胺钾、水合肼为原料,经溴代和Gabriel反应得到6-氨甲基喹啉。结果目标化合物经MS、1H-NMR确证化学结构,总产率达到47.5%。结论为6-甲基喹啉的制备提供了一条较为合理的工艺路线。 Objective To improve the synthesis of 6-aminomethylquinoline. Methods The 6-aminomethylquinoline was synthesized by using 6-methylquinoline,N-bromosuccinimide potassium phthalimide, and hydrazine hydrate as materials by bromination reaction and Gabriel reaction. Results The chemical structure of the target compound was confirmed by MS, 1H-NMR. The overall yield of title compound was 47.5%. Conclusions This article can provide a more reasonable route for the production process of 6-aminomethylquinoline.
出处 《广东药学院学报》 CAS 2014年第3期285-287,共3页 Academic Journal of Guangdong College of Pharmacy
基金 广东省战略性新兴产业核心技术攻关计划项目(2012A080800012)
关键词 6-氨甲基喹啉 溴代反应 Gabriel反应 合成 6-aminomethylquinoline bromination reaction Gabriel reaction synthesis
  • 相关文献

参考文献20

  • 1LIU Xiangdong,YAO Wenqin,NEWTON R C,et al. Targeting the c-MET signaling pathway for cancer therapy[J]. Expert Opin Invest Drugs, 2008 , 17 ( 7) : 997 -10 11.
  • 2DANILKOVITCH- MIAGKOV A A, ZBAR B. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors[J]. J Clin Invest ,2002, 109 ( 7) : 863-867.
  • 3PERUZZI B, BOTT ARDO D P. Targeting the c- Met signaling pathway[J].Clin Cancer Res, 2006, 12 ( 12) : 3657-3660.
  • 4ALBRECHT B K, HARMANGE J C, BAUER D, et al. Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the coMet kinase[J]. J Med Chem,2008,51( 10) :2879-2882.
  • 5LU Tianbao, ALEXANDER R, CONNORS R W, et al. Triazolopyridazines as tyrosine kinase modulators: WO, 075567[P J. 2007 -07 -05.
  • 6TIMOFEEVSKI S L, MCTIGUE M A, RYAN K, et al. Enzymatic characterization of c-Met receptor tyrosine kinase oncogenic mutants and kinetic studies with aminopyridine and triazolopyrazine inhibitors[J]. Biochemistry, 2009 , 48 (23) :5339-5349.
  • 7UNDERINER T L, HERBERTZ T, MIKNYOCZKI S J. Discovery of small molecule c-Met inhibitors: evolution and profiles of clinical candidates[J]. Anti -Cancer Agents Med Chem ,2010(10) : 7-27.
  • 8ZHUO Jincong, ZHANG Colin, XU Meizhong, et al. Triazolotriazine as kinase inhibitor: US, 7915408[P]. 2012- 03-27.
  • 9BOUNAUD P, JEFFERSON E A, LEE P S, et al. Triazolopyridazine protein kinase modulators: US, 8071581[P].2011-12-06.
  • 10JOSEPH P E, GEORGE F V W, SCOTT A B, et al. Novel therapeutic inhibitors of the c-Met signaling pathway in Cancer[J]. Clin Cancer Res,2009,15(7) :2207-2214.

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部